230615-70-0 2,2,2-trifluoro-1- (6,7,9,10-tetrahydro-8H-6, 10methanoazepino [4,5-g] quinoxalin-8-yl) ethan-1-one 98%

Founded in the year 2014
Fully owned subsidiary of V-Ensure Pharma Technologies Pvt. Ltd. a leading organization engaged into Contract Development & Manufacturing of finished dosage
20+ APIs developed and DMFs filed in the advanced market through the manufacturing facilities approved by FDA and EU GMP
30+ intermediates currently being offered
2 first to file (FTFs) successfully managed with the APIs developed by SKVEN

Vision
To be a well-recognized partner for APIs and chemicals by creating sustainable solutions for the pharmaceutical industry.

Mission
To be a leading player in the field of R&D and commercial manufacturing for starting materials, intermediates, active ingredients (APIs) with highest service levels in the pharma value chain.